← Browse by Condition
Medical Condition

vagus nerve stimulation

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for vagus nerve stimulation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — vagus nerve stimulation Clinical Trials

How many clinical trials are currently recruiting for vagus nerve stimulation?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for vagus nerve stimulation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for vagus nerve stimulation?
vagus nerve stimulation research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a vagus nerve stimulation clinical trial?
Eligibility criteria for vagus nerve stimulation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
Northwestern University 1 trial
University of Wisconsin, Madison 1 trial
Peking University First Hospital 1 trial

Recruiting Clinical Trials

NCT07610655
Recruiting
Effects of Transcutaneous Vagal Nerve Stimulation on Post-Surgical Return to Consciousness, Delirium, and Depression
Enrollment
40 pts
Location
United States
Sponsor
Northwestern University
View Trial →
NCT05866471 Phase 1
Recruiting
The ENHANCE Study: taVNS and Psilocybin
Enrollment
108 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
View Trial →
NCT06957912
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation and Quality of Recovery After Major Noncardiac Surgery
Enrollment
320 pts
Location
China
Sponsor
Peking University First Hospit...
View Trial →

Related Conditions

post operative delirium (1) cognitive impairment (1) depression (1) healthy (1) psychedelic experiences (1) transcutaneous electric nerve stimulation (1) noncardiac surgery (1) quality of recovery (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology